文献速递认知障碍与痴呆

遗传性额颞叶痴呆参与者的行为与神经精神症状的频率及纵向病程

Frequency and Longitudinal Course of Behavioral and Neuropsychiatric Symptoms in Participants With Genetic Frontotemporal Dementia.
PubMed 文献 · Neurology · 2024-09-16

研究纳入522例来自遗传性额颞叶痴呆倡议队列的致病性变异携带者(c9orf72、GRN或MAPT基因),通过主成分分析识别出5个行为与神经精神症状表型聚类,并分析其与脑萎缩的关联及纵向病程。结果显示情感症状在各基因群中最常见(83.6%-88.1%),不同基因群症状频率存在差异,且症状严重程度受时间、基因、性别和教育影响。

要点

  • 遗传性额颞叶痴呆中识别出5个行为与神经精神症状聚类,解释67.6%的方差。
  • 情感症状在各基因群中最常见(83.6%-88.1%),其次为多样行为症状(68.4%-77.9%)。
  • c9orf72和GRN携带者精神病性症状较欣快/性欲亢进症状更常见,MAPT携带者相反。

核心结论

  • 在遗传性额颞叶痴呆参与者中识别出多个行为与神经精神症状聚类,这些聚类与不同的脑萎缩模式相关。
  • 症状严重程度取决于时间、受累基因、性别和教育。
  • 这些临床-遗传关联可指导诊断评估以及新疾病修饰和预防性治疗的临床试验设计。

研究设计与样本

  • 分析来自遗传性额颞叶痴呆倡议队列研究的c9orf72、GRN或MAPT基因致病性变异携带者数据,该队列纳入症状性携带者和已知携带者的一级亲属。
  • 共纳入522例参与者:221例c9orf72(138例症状前)、213例GRN(157例症状前)、88例MAPT(62例症状前)致病性变异携带者。
  • 采用主成分分析识别行为与神经精神聚类,使用基于体素的形态测量学确定聚类与MRI评估萎缩的关联,应用线性混合效应和广义线性混合效应模型评估症状纵向病程。

主要发现

  • 主成分分析揭示5个表型聚类(解释67.6%的方差),标记为多样行为、情感、精神病性、欣快/性欲亢进和触觉幻觉表型。
  • 在表现行为或神经精神症状的参与者中,情感症状在各组中最常见(83.6%-88.1%),其次为多样行为症状(68.4%-77.9%)。
  • 在c9orf72和GRN致病性变异携带者中,精神病性症状(分别为32.0%和19.4%)比欣快/性欲亢进症状(分别为28.7%和14.2%)更常见,而在MAPT致病性变异携带者中情况相反(分别为28.6%和23.8%)。
  • 多样行为症状与灰质和白质额颞叶萎缩相关,而精神病性症状仅与右侧丘脑一个小萎缩簇相关;欣快/性欲亢进症状与内侧颞叶、基底前脑结构和纹状体萎缩相关(p < 0.05)。
  • 估计症状发作时间、基因分组、教育和性别影响行为与神经精神症状(p < 0.05);特别是在c9orf72致病性变异携带者中,精神病性症状可能在识别疾病发作前数十年即开始。

关键数值与推荐

  • 5个表型聚类解释67.6%的方差。
  • 情感症状频率83.6%-88.1%,多样行为症状频率68.4%-77.9%。
  • c9orf72携带者精神病性症状32.0%、欣快/性欲亢进症状28.7%;GRN携带者分别为19.4%和14.2%;MAPT携带者分别为28.6%和23.8%。
  • 萎缩关联显著性阈值p < 0.05。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Behavioral and neuropsychiatric symptoms are frequent in patients with genetic frontotemporal dementia (FTD). We aimed to describe behavioral and neuropsychiatric phenotypes in genetic FTD, quantify their temporal association, and investigate their regional association with brain atrophy. METHODS: We analyzed data of pathogenic variant carriers in the chromosome 9 open reading frame 72 (c9orf72), progranulin (GRN), or microtubule-associated protein tau (MAPT) gene from the Genetic Frontotemporal dementia Initiative cohort study that enrolls both symptomatic pathogenic variant carriers and first-degree relatives of known carriers. Principal component analysis was performed to identify behavioral and neuropsychiatric clusters that were compared with respect to frequency and severity between groups. Associations between neuropsychiatric clusters and MRI-assessed atrophy were determined using voxel-based morphometry. We applied linear mixed effects and generalized linear mixed effects models to assess the longitudinal course of symptoms. RESULTS: A total of 522 participants were included: 221 c9orf72 (138 presymptomatic), 213 GRN (157 presymptomatic), and 88 MAPT (62 presymptomatic) pathogenic variant carriers. Principal component analysis revealed 5 phenotypic clusters (67.6% of variance), labeled diverse behavioral, affective, psychotic, euphoric/hypersexual, and tactile hallucinations phenotype. In participants presenting behavioral or neuropsychiatric symptoms, affective symptoms were most frequent across groups (83.6%-88.1%), followed by diverse behavioral symptoms (68.4%-77.9%). In c9orf72 and GRN pathogenic variant carriers, psychotic symptoms (32.0% and 19.4%, respectively) were more frequent than euphoric/hypersexual symptoms (28.7% and 14.2%, respectively), which was the other way around in MAPT pathogenic variant carriers (28.6% and 23.8%). Although diverse behavioral symptoms were associated with gray and white matter frontotemporal atrophy, only a small atrophy cluster in the right thalamus was associated with psychotic symptoms. Euphoric/hypersexual symptoms were associated with atrophy in mesial temporal lobes, basal forebrain structures, and the striatum (p < 0.05). Estimated time to symptom onset, genetic group, education, and sex influenced behavioral and neuropsychiatric symptoms (p < 0.05). Particularly, in c9orf72 pathogenic variant carriers, psychotic symptoms may be starting decades before recognition of onset of illness. DISCUSSION: We identified multiple clusters of behavioral and neuropsychiatric symptoms in participants with genetic FTD that relate to distinct cerebral atrophy patterns. Their severity depends on time, affected gene, sex, and education. These clinical-genetic associations can guide diagnostic evaluations and the design of clinical trials for new disease-modifying and preventive treatments.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Schönecker S, Martinez-Murcia FJ, Denecke J, et al. Frequency and Longitudinal Course of Behavioral and Neuropsychiatric Symptoms in Participants With Genetic Frontotemporal Dementia. Neurology. 2024. PMID: 39284109. doi:10.1212/WNL.0000000000209569

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。